Importin α1 (Rch1) Mediates Nuclear Translocation of Thioredoxin-binding Protein-2/Vitamin D3-up-regulated Protein 1

Yumiko Nishinaka, Hiroshi Masutani, Shinichi Oka, Yoshiyuki Matsuo, Yoshimi Yamaguchi, Keiko Nishio, Yasuyuki Ishii, Junji Yodoi

Journal of Biological Chemistry · 2004 · 129 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

Thioredoxin-binding protein-2 (TBP-2)/vitamin D3 up-regulated protein 1 is an endogenous molecule interacting with thioredoxin (TRX), negatively regulating TRX function, and being implicated in the suppression of tumor development and metastasis. We found that TBP-2 ectopically expressed in the breast cancer cell line MCF-7 was localized predominantly in the nucleus exhibiting growth suppressive activity. The nuclear accumulation of endogenous TBP-2 protein was also demonstrated when the cells were treated with an anti-cancer drug, suberoylanilide hydroxamic acid. To investigate the mechanism underlying the nuclear localization, we performed a yeast two-hybrid screening and identified importin α1 (Rch1) as a protein interacting with TBP-2. The physical interaction between TBP-2 and Rch1 was confirmed with a glutathione S-transferase pull-down assay. The interaction of TBP-2 was specific to Rch1 among other importin α subfamilies (Qip1 and NPI-1), and amino acids 1–227 of TBP-2 were sufficient for both the interaction with Rch1 and the nuclear localization, although there is no typical nuclear localization signal in this sequence. The expression of short interfering RNA of Rch1 suppressed suberoylanilide hydroxamic acid-induced nuclear accumulation of TBP-2. Collectively, our results strongly suggest that an interaction with importin system is required for TBP-2 nuclear translocation and growth control tightly associated with TRX-dependent redox regulation of transcription factors. Thioredoxin-binding protein-2 (TBP-2)/vitamin D3 up-regulated protein 1 is an endogenous molecule interacting with thioredoxin (TRX), negatively regulating TRX function, and being implicated in the suppression of tumor development and metastasis. We found that TBP-2 ectopically expressed in the breast cancer cell line MCF-7 was localized predominantly in the nucleus exhibiting growth suppressive activity. The nuclear accumulation of endogenous TBP-2 protein was also demonstrated when the cells were treated with an anti-cancer drug, suberoylanilide hydroxamic acid. To investigate the mechanism underlying the nuclear localization, we performed a yeast two-hybrid screening and identified importin α1 (Rch1) as a protein interacting with TBP-2. The physical interaction between TBP-2 and Rch1 was confirmed with a glutathione S-transferase pull-down assay. The interaction of TBP-2 was specific to Rch1 among other importin α subfamilies (Qip1 and NPI-1), and amino acids 1–227 of TBP-2 were sufficient for both the interaction with Rch1 and the nuclear localization, although there is no typical nuclear localization signal in this sequence. The expression of short interfering RNA of Rch1 suppressed suberoylanilide hydroxamic acid-induced nuclear accumulation of TBP-2. Collectively, our results strongly suggest that an interaction with importin system is required for TBP-2 nuclear translocation and growth control tightly associated with TRX-dependent redox regulation of transcription factors. We recently identified thioredoxin binding protein-2 (TBP-2), 1The abbreviations used are: TBP-2, thioredoxin-binding protein-2; TRX, thioredoxin; SAHA, suberoylanilide hydroxamic acid; mAb, monoclonal antibodies; GFP, green fluorescent protein; EGFP, enhanced GFP; GST, glutathione S-transferase; STAT, signal transducers and activators of transcription; NLS, nuclear localization signal. identical to vitamin D3 up-regulated protein 1 (1Chen K.S. DeLuca H.F. Biochim. Biophys. Acta. 1994; 1219: 26-32Crossref PubMed Scopus (274) Google Scholar), as a regulatory molecule interacting with thioredoxin (TRX) (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar). Later, several other reports confirmed the functional association between TBP-2/vitamin D3 up-regulated protein 1 and TRX (3Junn E. Han S.H. Im J.Y. Yang Y. Cho E.W. Um H.D. Kim D.K. Lee K.W. Han P.L. Rhee S.G. Choi I. J. Immunol. 2000; 164: 6287-6295Crossref PubMed Scopus (401) Google Scholar, 4Yamanaka H. Maehira F. Oshiro M. Asato T. Yanagawa Y. Takei H. Nakashima Y. Biochem. Biophys. Res. Commun. 2000; 271: 796-800Crossref PubMed Scopus (102) Google Scholar). TRX, a small ubiquitous protein with conserved redox active sites, plays pivotal roles in regulating cell proliferation, apoptosis, and the activation of transcription factors by maintaining a reducing intracellular microenvironment (5Nishinaka Y. Masutani H. Nakamura H. Yodoi J. Redox. Rep. 2001; 6: 289-295Crossref PubMed Scopus (75) Google Scholar). TBP-2 has been demonstrated to inhibit the reducing activity of TRX in vitro and in vivo (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar, 3Junn E. Han S.H. Im J.Y. Yang Y. Cho E.W. Um H.D. Kim D.K. Lee K.W. Han P.L. Rhee S.G. Choi I. J. Immunol. 2000; 164: 6287-6295Crossref PubMed Scopus (401) Google Scholar). Recent reports demonstrated that TBP-2 expression is up-regulated in cells treated with anti-cancer reagents, such as suberoylanilide hydroxamic acid (SAHA) (6Butler L.M. Zhou X. Xu W.S. Scher H.I. Rifkind R.A. Marks P.A. Richon V.M. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 11700-11705Crossref PubMed Scopus (463) Google Scholar), and down-regulated in various tumor cells (6Butler L.M. Zhou X. Xu W.S. Scher H.I. Rifkind R.A. Marks P.A. Richon V.M. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 11700-11705Crossref PubMed Scopus (463) Google Scholar, 7Ikarashi M. Takahashi Y. Ishii Y. Nagata T. Asai S. Ishikawa K. Anticancer Res. 2002; 22: 4045-4048PubMed Google Scholar). A regulatory role of TBP-2 in the metastasis associated with CRSP3, a transcriptional co-activator on chromosome 6, was also suggested (8Goldberg S.F. Miele M.E. Hatta N. Takata M. Paquette-Straub C. Freedman L.P. Welch D.R. Cancer Res. 2003; 63: 432-440PubMed Google Scholar). These findings imply the possible involvement of TBP-2 in the regulation of tumor development, progression, and metastasis. Interestingly, a nonsense mutation of the mouse TBP-2 gene (Hyplip1) was identified as a possible cause of hyperlipidemia (9Bodnar J.S. Chatterjee A. Castellani L.W. Ross D.A. Ohmen J. Cavalcoli J. Wu C. Dains K.M. Catanese J. Chu M. Sheth S.S. Charugundla K. Demant P. West D.B. de Jong P. Lusis A.J. Nat. Genet. 2002; 30: 110-116Crossref PubMed Scopus (180) Google Scholar), implicating that TBP-2 is involved in lipid metabolism as well. An immediate up-regulation of TBP-2 mRNA expression by glucose has also been reported (10Hirota T. Okano T. Kokame K. Shirotani-Ikejima H. Miyata T. Fukada Y. J. Biol. Chem. 2002; 277: 44244-44251Abstract Full Text Full Text PDF PubMed Scopus (261) Google Scholar). Although TBP-2 is involved in a wide variety of biological functions, its physiological functions are not well understood and the underlying mechanisms are unknown. In this study, we show that TBP-2 predominantly localizes in the nucleus associated with its growth-suppressive activity. In addition, we have identified a member of the importin α family, Rch1, as a protein interacting with TBP-2 based on a yeast two-hybrid screen. The import of many proteins into the nucleus is mediated by the importin system (11Yoneda Y. Genes Cells. 2000; 5: 777-787Crossref PubMed Scopus (169) Google Scholar). Our results suggest that TBP-2 is translocated into the nucleus by a mechanism involving the importin system to function as a growth suppressor. Chemicals and Antibodies—SAHA and doxycycline (Dox) were purchased from ALEXIS Biochemicals (Carlsbad, CA) and Sigma, respectively. The primary antibodies used were as follows: anti-FLAG M2 monoclonal antibody (mAb) from Sigma; anti-GFP mAb from Medical & Biological Laboratories (Nagoya, Japan); and anti-TRX mAb (ADF11) described previously (12Kogaki H. Fujiwara Y. Yoshiki A. Kitajima S. Tanimoto T. Mitsui A. Shimamura T. Hamuro J. Ashihara Y. J. Clin. Lab. Anal. 1996; 10: 257-261Crossref PubMed Scopus (36) Google Scholar). DNA Constructs—The full-length cDNA of human TBP-2 was cloned in-frame into each of the vectors, pGBKT7, pEGFP, pTRE2 (Clontech), or pCMV-Tag2 (Stratagene). TBP-2 deletion mutant vectors (pGBKT7-TBP-2-Δ(1–120), pGBKT7-TBP-2-Δ(121–227), and pGBKT7-TBP-2-(121–227)) were prepared by PCR cloning and subsequent ligation into TOPO-cloning vector (Invitrogen) followed by ligation into the NdeI-EcoRI cloning sites of pGBKT7. The cDNA of Rch1 was cloned in-frame into pCMV-Tag2 to produce pCMV-Rch1. All of the constructs were verified by sequencing. Listed below are primers used for amplification. Each primer contains a new restriction site, NdeI or KpnI (underlined). All of the sequences are in the 5′ to 3′ orientation, and the direction, forward (F) or reverse (R), is indicated as follows: pr1F, 5′-CCATATGGTGATGTTCAAGAAGATCAAG-3′; pr391R, 5′-GGGTACCTCACTGCACATTGTTGTTG-3′; pr121F, 5′-TCCATATGGTAGACTACTGGGTGAAGGC-3′; and pr227R, 5′-GGGTACCGGTCTGGCCATTGGCAAGGTA-3′. To construct a series of pEGFP plasmids, the fragments containing deletion mutants, which were prepared using either the appropriate restriction enzyme or PCR with appropriate oligonucleotides, were inserted in-frame into the vector pEGFP. The integrity of all of the constructs was confirmed before use. cDNAs containing importin α1 (Rch1), importin α3 (Qip1), and importin α5 (NPI-1) were kindly provided by Dr. Yoneda (Osaka University) and were cloned in-frame into the vector pACT2. The pSUPER-Rch1 expression vectors were constructed by inserting oligonucleotides into BglII/HindIII site of pSUPER (OligoEngine). Oligonucleotides inserted into pSUPER-Rch1–2 and pSUPER-Rch1–3 were as follows: pSUPER-Rch1–2 ((forward) 5′-GATCCCCGTGCGGTGCAGTTGACTCATTCAAGAGATGGGTCAACTGCACCGTACTTTTTGGAAA-3′ and (reverse) 5′-AGCTTTCCAAAAAGTACGGTGCAGTTGACCCATCTCTTGAATGAGTCAACTGCACCGCACGGG-3′) and pSUPER-Rch1–3 ((forward) 5′-GATCCCCCTATACTAGTGGTGGAGCATTCAAGAGATGTTCCACCACTGGTATAGTTTTTGGAAA-3′ and (reverse) 5′-AGCTTTTCCAAAAACTATACCAGTGGTGGAACATCTCTTGAATGCTCCACCACTAGTATAGGGG-3′). Cell Culture and Transfections—COS-7 and MCF-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 units/ml penicillin G, and 100 μg/ml streptomycin at 37 °C in a humidified 5% CO2 atmosphere. For transfection, cells were seeded at 70% confluence and transfected with each DNA using FuGENE 6. MCF-7 Tet-On cells (Clontech) were transfected with pTRE2-EGFP-TBP-2 or pTRE2-EGFP. After 24 h, cells were plated and selected in medium containing 2.5 μg/ml puromycin (Sigma). The induction of EGFP-TBP-2 or EGFP expression by Dox in the resistant clones was confirmed by Western blotting with the anti-GFP mAb and by fluorescence microscopy. Western Blot Analysis—Cell lysates were prepared with lysis buffer (150 mm NaCl, 1% Nonidet P-40, 1% deoxycholate, 0.1% SDS, 20 mm Tris-HCl, pH 7.5, and protease inhibitors). Nuclear extracts were prepared as described previously (13Andrews N.C. Faller D.V. Nucleic Acids Res. 1991; 19: 2499Crossref PubMed Scopus (2211) Google Scholar). Cell lysates containing equal amounts of protein were separated by SDS-PAGE, electroblotted to a polyvinylidene difluoride membrane, probed with each antibody, and visualized by chemiluminescent detection (ECL, Amersham Biosciences). Anti-nucleoporin p62 antibody was purchased from Transduction Laboratories. Cell Proliferation Assay—Cells (103 cells/well) were cultured in 96-well flat-bottom microtiter plates (Nunc) in triplicate. At different time points of culture (1–3 days), cell proliferation was assessed using a WST-1 cell proliferation assay kit (TaKaRa). Establishment of Anti-TBP-2 mAbs—Recombinant TBP-2 protein was prepared as described previously (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar). Spleen cells from BALB/c mice immunized with recombinant TBP-2 protein were fused with the murine myeloma cell line P3-X63 using and cultured in medium containing and 5% medium TBP-2 protein were cloned by the and of used in this were and were treated with or for 20 were with for and endogenous activity was by with in for All of the subsequent were performed with S. S. M. H. 2003; PubMed Scopus Google Scholar). binding was by with 1% in and cells were with mAb for The were and with and with for was visualized with amounts of protein were with activation buffer mm containing 1 and for at 37 The were with a mm mm units/ml yeast TRX and and at The in at was at a were with the The were with the for recombinant TRX to of the amounts of from was used to the was into yeast and selected were and with a human cDNA were prepared from growth on a and medium and from that were for activity. the clones of the cDNA clones were selected and into for sequencing. S-transferase expression of full-length Rch1 or TBP-2 as a protein from was performed as described previously (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar). The proteins using the system were with containing of or were in binding buffer (150 mm NaCl, 1% Nonidet P-40, mm and protease at °C for with TBP-2 or Rch1, which to the or was by All of the results were confirmed in at of the functional roles of TBP-2, MCF-7 EGFP-TBP-2 and were The induction of EGFP-TBP-2 expression by Dox was confirmed by Western We the of TBP-2 expression on the cell growth of MCF-7 by activity. The and growth in a control EGFP no in its cell growth In the which expressed a of cell growth suppression was not These results that of TBP-2 results in growth Nuclear of TBP-2 with of the MCF-7 clones EGFP-TBP-2 a nuclear localization of the protein in a A and In a EGFP-TBP-2 a nuclear results were when cells were transfected with and EGFP protein was the cells To the localization of endogenous TBP-2, we specific to TBP-2. selected and TBP-2 protein in cells treated with vitamin D3 and ectopically in human cell line by Western blotting with the antibody, endogenous TBP-2 was not in MCF-7 cells SAHA, a has been demonstrated to TBP-2 expression (6Butler L.M. Zhou X. Xu W.S. Scher H.I. Rifkind R.A. Marks P.A. Richon V.M. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 11700-11705Crossref PubMed Scopus (463) Google Scholar), MCF-7 cells treated with were used to the expression of TBP-2. The induction of TBP-2 by was in the nuclear in the with the Western that TBP-2 is in the nuclear of MCF-7 cells The was to the expression of p62 was of nuclear localization of endogenous TBP-2 by specific detection of TBP-2 protein with and cell were prepared by with or TBP-2 protein expression in cells was by with vitamin D3 (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar). vitamin detection of endogenous TBP-2 in MCF-7 cells treated with MCF-7 cells were cultured in the or of for 20 h, and endogenous TBP-2 was by with Western of endogenous TBP-2 protein and p62 in the and nucleus of MCF-7 MCF-7 cells were cultured in the or of for 20 h, and and nuclear of MCF-7 cells were of TBP-2 with TBP-2 has been demonstrated to with TRX, we the of TBP-2 and TRX in the MCF-7 D3 using microscopy. D3 cells were cultured in the of TRX was expressed in both the nucleus and TBP-2 was found predominantly in the that TBP-2 and TRX are in the nucleus of cells To the functional association with TRX, the expression and reducing activity of TRX was in D3 cells cultured in the or of The results show that the reducing activity of TRX was the protein expression of TRX were not of Rch1 as a using a proteins that TBP-2 nuclear we performed a yeast two-hybrid screening of a cDNA clones a protein Rch1 which in clones and an of The other clones different of the were of the of Rch1 in-frame Rch1 protein into an the importin binding a of and a short binding The of Rch1 clones identified in our screening and the at which each are indicated in These findings indicated that the are maintained in all of the the of the for the interaction between TBP-2 and clones proteins protein and Rch1 to TBP-2 in a the physical interaction between Rch1 and TBP-2, a pull-down assay was that TBP-2 with The of the interaction was confirmed by the that TBP-2 not to of The binding between TBP-2 and was with reports (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar, 3Junn E. Han S.H. Im J.Y. Yang Y. Cho E.W. Um H.D. Kim D.K. Lee K.W. Han P.L. Rhee S.G. Choi I. J. Immunol. 2000; 164: 6287-6295Crossref PubMed Scopus (401) Google Scholar, 4Yamanaka H. Maehira F. Oshiro M. Asato T. Yanagawa Y. Takei H. Nakashima Y. Biochem. Biophys. Res. Commun. 2000; 271: 796-800Crossref PubMed Scopus (102) Google Scholar). were performed using Rch1 and TBP-2 fused to Rch1 to not to either or between TBP-2 and there are at importin α and into Rch1, and amino acid (11Yoneda Y. Genes Cells. 2000; 5: 777-787Crossref PubMed Scopus (169) Google Scholar). we the binding between TBP-2 and the importin α subfamilies using a yeast two-hybrid assay. in TBP-2 with Rch1 not with or We Rch1 the nuclear import of TBP-2 using different constructs of Rch1 expression vectors Rch1 expression was using pSUPER-Rch1–2 and pSUPER-Rch1–3 The suppression of Rch1 expression by of vectors suppressed nuclear expression of TBP-2 the expression of TBP-2 of TBP-2 with to no nuclear localization signal in TBP-2. We used a series of deletion of TBP-2 to interacting we the possible of TBP-2 interacting with Rch1 with a yeast two-hybrid assay. The results that was of interacting with and no interaction with Rch1 We constructed a series of deletion and the localization of proteins using microscopy. with the results on Rch1 maintained predominantly a nuclear localization a localization the and nucleus The results are in we demonstrated that when TBP-2 was cell growth was suppressed in a breast cancer cell MCF-7 The growth-suppressive activity of TBP-2 in cells is associated with cell at the S.H. U. Kim Lee K.S. Yang Y. Lee Choi I. 2003; 22: PubMed Scopus Google Scholar). Our also that the of TBP-2 in human cell in association with an accumulation of the protein Y. A. Masutani H. S. K.M. Y. Ishii Y. Nakamura H. M. Yodoi J. Cancer Res. PubMed Scopus Google Scholar). the protein has been reported not to functional in MCF-7 The mechanism involved in the activity on cell TBP-2 is a of TRX (2Nishiyama A. Matsui M. Iwata S. Hirota K. Masutani H. Nakamura H. Takagi Y. Sono H. Gon Y. Yodoi J. J. Biol. Chem. 1999; 274: 21645-21650Abstract Full Text Full Text PDF PubMed Scopus (595) Google Scholar), and reports have suggested that the of TBP-2 expression are associated with TRX activity (6Butler L.M. Zhou X. Xu W.S. Scher H.I. Rifkind R.A. Marks P.A. Richon V.M. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 11700-11705Crossref PubMed Scopus (463) Google Scholar, J.S. Chatterjee A. Castellani L.W. Ross D.A. Ohmen J. Cavalcoli J. Wu C. Dains K.M. Catanese J. Chu M. Sheth S.S. Charugundla K. Demant P. West D.B. de Jong P. Lusis A.J. Nat. Genet. 2002; 30: 110-116Crossref PubMed Scopus (180) Google Scholar, J. Lee Res. 2002; PubMed Scopus Google Scholar, Y. Lee J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). we the of TBP-2 on the protein expression and the reducing activity of Although the protein expression of TRX was not the reducing activity was in treated with TRX has a variety of biological functions cell the of TRX functions by TBP-2 at the growth-suppressive of TBP-2. An of the is that TBP-2 and TRX are not TRX has been to translocated into the nucleus in to various K. M. Y. Nakamura H. J. K. Yodoi J. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar). These findings suggest that the of between TBP-2 and TRX in the nucleus is a on the redox of is possible that the induction of the nuclear accumulation of TRX, the interaction of TBP-2 and TRX is the growth-suppressive of TBP-2. We nuclear localization of TBP-2 in MCF-7 and cells transfected with EGFP fused to TBP-2, the localization of TBP-2. we specific to TBP-2 and to the localization of the endogenous TBP-2 The antibodies the of TBP-2 not and were to TBP-2 by vitamin D3 in cells or ectopically expressed in cells We to the localization of endogenous TBP-2 in MCF-7 cells by is a of and is to growth and in many tumor and has been reported to TBP-2 expression in several tumor cell (6Butler L.M. Zhou X. Xu W.S. Scher H.I. Rifkind R.A. Marks P.A. Richon V.M. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 11700-11705Crossref PubMed Scopus (463) Google Scholar). MCF-7 cells were treated with and to an of TBP-2 expression by and Western mAb, endogenous TBP-2 expression was found to up-regulated predominantly in the nucleus of MCF-7 cells and These results suggest that enhanced TBP-2 expression in the nucleus is associated with growth suppression in to To investigate the mechanism of TBP-2 nuclear we performed a yeast two-hybrid screening of a cDNA and identified Rch1 as a molecule interacting with TBP-2. In a different yeast two-hybrid screening using a cDNA several clones Rch1 were also selected not These results suggest that TBP-2 with Rch1 in various of are as nuclear α proteins proteins the the and to importin translocation the nuclear (11Yoneda Y. Genes Cells. 2000; 5: 777-787Crossref PubMed Scopus (169) Google Scholar, M. Biochem. Cell Biol. 2001; PubMed Scopus Google Scholar). Our results demonstrated that amino acids 1–227 of TBP-2 were sufficient for the interaction with Rch1, although there to no in the of TBP-2. and not with Rch1, the interaction between TBP-2 and Rch1 a or sequences in amino acids The of TBP-2 deletion also that amino acids 1–227 of TBP-2 were sufficient for the nuclear localization, with the results for the Although gene for importin is several importin α and are into such as importin α1 (Rch1), importin α3 (Qip1), and importin α5 These subfamilies show in sequences and import the to reports on importin α proteins S.G. J. J.S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar), is that other importin α cDNAs are in the human cell has also been suggested that different importin α proteins have both different and for the various and are by of the importin α proteins Rch1, and M. C. M. S. H. E. Biol. 1999; 19: PubMed Google Scholar), T. N. K. T. Yoneda Y. J. PubMed Scopus Google and M. C. M. S. H. E. Biol. 1999; 19: PubMed Google are by and respectively. is the of sequences that by each importin α we the for TBP-2 of the importin α subfamilies and Our results that TBP-2 with Rch1 not with or The of Rch1 expression vectors suppressed nuclear expression of TBP-2 and the expression of TBP-2 These results suggest that the nuclear of TBP-2 is mediated by The of the interaction between TBP-2 and Rch1 We demonstrated that TBP-2 protein by with or by of the TBP-2 gene is predominantly localized to the These suggest that TBP-2 is enhanced and into the nucleus to its physiological functions growth-suppressive activity. we have a of TBP-2 in the nucleus and The as the induction of TBP-2 expression not A by Han S.H. U. Kim Lee K.S. Yang Y. Lee Choi I. 2003; 22: PubMed Scopus Google the interaction and of TBP-2 with transcriptional such as and and that the a in the We also have several nuclear proteins that are for the regulation of transcriptional as of TBP-2 not These suggest that the interaction of nuclear proteins nuclear expression of TBP-2 is associated with the growth-suppressive activity of TBP-2. In our Rch1 the interaction between TBP-2 and the functions of several TRX binding are by a interaction with TRX, TRX a role in regulating the nuclear translocation of TBP-2 mediated by Rch1 and growth suppression in a as well. We and Hirota for and Dr. Yoneda for of the importin α family, for and for

References

21